How Do Wegovy And Mounjaro Starter Doses Compare?
Understanding The Switch From Wegovy To Mounjaro: Starter Dose Considerations
When evaluating whether to switch from Wegovy to Mounjaro, the starter dose protocols represent a fundamental difference between these prescription-only medicines. Wegovy begins with a 0.25mg dose for the first four weeks, designed to minimise initial side effects whilst allowing your body to adapt to semaglutide's GLP-1 receptor activity. Mounjaro follows a different approach with its 2.5mg starting dose of tirzepatide, reflecting the dual GIP and GLP-1 receptor targeting mechanism. Both treatments require careful dose escalation under medical supervision, but the pathways and timeframes differ significantly.
The decision to switch from Wegovy to Mounjaro often stems from individual response variations, tolerability concerns, or clinical recommendations based on your specific health profile. Some patients find Wegovy's gradual 16-week escalation schedule suits their tolerance levels, whilst others may benefit from Mounjaro's alternative dosing pathway and dual hormone approach. Your prescriber will evaluate factors including your current Wegovy dose, treatment duration, response patterns, and any side effects experienced before recommending a switch. At EverydayMeds, our clinical team can facilitate this transition with proper medical oversight and supply continuity.
Wegovy Starter Dose Pricing And Value At EverydayMeds
Our Wegovy 0.25mg starter dose costs £79.99 with the FIRST40 discount code applied at checkout for new customers. This competitive pricing includes the complete FlexTouch pen system with four weekly injections, providing exceptional value for your initial month of treatment. For patients planning their dose escalation journey, our Intro Duo bundle combines the 0.25mg and 0.5mg doses for £169.99, offering convenient supply for weeks 1-8 without multiple orders. Returning customers benefit from the DOSE25 discount code, maintaining affordability throughout their treatment pathway.
When comparing the cost implications of switching from Wegovy to Mounjaro, consider that both treatments require similar long-term investment patterns, though with different dose escalation schedules and maintenance costs. EverydayMeds provides transparent pricing for both options, allowing you to make informed financial decisions alongside clinical considerations. Our bundle options, including the Intro Trio (0.25mg, 0.5mg, and 1mg) at £299.99, provide supply security during the critical initial months when establishing tolerance and response patterns. All prices include our comprehensive service covering clinical assessment, prescriber review, and next-day cold-chain delivery.
Clinical Evidence For Wegovy Versus Mounjaro In Weight Management
In clinical trials, patients taking Wegovy alongside diet and exercise achieved an average of approximately clinically studied weight loss at 68 weeks in the STEP 1 trial (Wilding et al., NEJM, 2021). The STEP programme demonstrated consistent efficacy across different patient populations, with the 0.25mg starter dose playing a crucial role in establishing tolerance before progression to the 2.4mg maintenance dose. These results support Wegovy's position as an effective weight management tool when combined with lifestyle interventions.
Mounjaro's clinical evidence from the SURMOUNT trials shows its own efficacy profile, though direct comparisons between trials should be interpreted cautiously due to different study designs and patient populations. Both medications represent evidence-based approaches to weight management, with the choice between them depending on individual patient factors rather than superior efficacy of one over the other. Your prescriber will consider your medical history, treatment goals, and previous responses when evaluating whether to switch from Wegovy to Mounjaro.
How Wegovy's Mechanism Supports Weight Management
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the action of naturally occurring incretin hormones in your digestive system. When you inject the weekly dose, semaglutide binds to GLP-1 receptors in the brain areas responsible for appetite regulation, promoting feelings of fullness and reducing food cravings. This mechanism slows gastric emptying, meaning food remains in your stomach longer, contributing to sustained satiety between meals. The 0.25mg starter dose begins this process gently, allowing your body to adapt to these hormonal changes whilst minimising potential gastrointestinal side effects. Unlike Mounjaro's dual GIP and GLP-1 approach, Wegovy focuses specifically on the GLP-1 pathway, providing a well-established mechanism for appetite control and weight management when combined with dietary and exercise modifications.
EverydayMeds Ordering Process For Both Treatments
Beginning your journey with either Wegovy or Mounjaro at EverydayMeds starts with our comprehensive 3-minute online clinical assessment, designed to capture your medical history, current medications, and weight management goals. Our qualified prescribers review your information within 3 working days (or 24 hours with express service), ensuring safe and appropriate treatment selection whether you're starting Wegovy or considering a switch from Wegovy to Mounjaro. Once approved, your medication ships via next-day delivery in temperature-controlled packaging, maintaining the cold-chain integrity essential for these prescription-only medicines. Our GPhC-registered pharmacy (#9012878) ensures all medications are genuine, properly stored, and dispensed with full regulatory compliance. The process includes ongoing clinical support, with our team available to address questions about dose progression, side effect management, or potential treatment switches throughout your weight management journey.
Storage Requirements And Practical Considerations
Wegovy requires refrigeration at 2-8°C before first use, but offers a significant practical advantage with up to 6 weeks of room temperature storage below 30°C once removed from the fridge. This extended stability makes Wegovy particularly suitable for travel or situations where consistent refrigeration isn't assured, compared to Mounjaro's 21-day room temperature limit. The FlexTouch pen system provides user-friendly injection with clear dose indicators and safety features designed for weekly self-administration. Each 0.25mg pen contains four doses for your starter month, with the dose escalation schedule progressing to 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), and finally 2.4mg maintenance dosing. Proper storage and handling ensure medication efficacy and safety throughout your treatment, whether continuing with Wegovy or transitioning to alternative therapies under medical supervision.
Evaluating Your Switch From Wegovy To Mounjaro Options
The decision to switch from Wegovy to Mounjaro typically involves careful evaluation of your current treatment response, tolerance profile, and clinical goals with your healthcare provider. Some patients consider switching due to plateau effects, side effect patterns, or specific clinical circumstances where the dual GIP/GLP-1 mechanism might offer advantages. However, switching between these prescription-only medicines requires medical supervision and careful timing to maintain treatment continuity whilst avoiding potential complications.
At EverydayMeds, we support patients through treatment transitions with clinical oversight and flexible supply options for both medications. Whether you ultimately continue with Wegovy's proven GLP-1 pathway or transition to Mounjaro's dual hormone approach, our clinical team ensures safe management of your weight loss journey. Both treatments remain available through our streamlined service, allowing your prescriber to recommend the most appropriate option based on your individual circumstances rather than formulary restrictions or supply limitations.
Begin Your Treatment Journey With Confidence
Starting your weight management journey with Wegovy's 0.25mg dose at £79.99 provides an accessible entry point to clinically proven semaglutide therapy, with new customers using code FIRST40 at checkout. Our comprehensive service includes clinical assessment, prescriber review, next-day delivery, and ongoing support throughout your dose escalation schedule. Whether you're beginning treatment or considering a switch from Wegovy to Mounjaro, EverydayMeds offers both options with the same high standards of clinical care and pharmaceutical excellence. Visit https://everydaymeds.co.uk/products/wegovy-0-25mg to begin your clinical assessment today. Both Wegovy and Mounjaro are available from EverydayMeds — your prescriber can help determine which treatment aligns best with your weight management goals and medical profile.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
